- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x CLR: CHOLESTEROL(Non-covalent)
- 38 x OCT: N-OCTANE(Non-functional Binders)(Non-covalent)
OCT.3: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPOCT.4: 8 residues within 4Å:- Chain A: Y.204, V.492, L.496
- Chain B: L.497, Y.501
- Ligands: D10.12, D10.14, C14.78
Ligand excluded by PLIPOCT.5: 2 residues within 4Å:- Ligands: OCT.6, D10.16
Ligand excluded by PLIPOCT.6: 4 residues within 4Å:- Chain A: I.60, F.64, R.197
- Ligands: OCT.5
Ligand excluded by PLIPOCT.8: 4 residues within 4Å:- Chain A: F.241, Y.245, F.481
- Ligands: OCT.9
Ligand excluded by PLIPOCT.9: 7 residues within 4Å:- Chain A: F.241, T.474, V.477
- Ligands: D10.7, OCT.8, OCT.27, C14.29
Ligand excluded by PLIPOCT.17: 1 residues within 4Å:- Chain A: F.307
Ligand excluded by PLIPOCT.19: 8 residues within 4Å:- Chain A: G.91, V.92, L.95, F.294, M.420, V.424, T.428
- Ligands: D10.18
Ligand excluded by PLIPOCT.24: 1 residues within 4Å:- Ligands: D12.23
Ligand excluded by PLIPOCT.27: 3 residues within 4Å:- Ligands: OCT.9, D10.28, C14.30
Ligand excluded by PLIPOCT.37: 2 residues within 4Å:- Chain A: M.267
- Ligands: HP6.38
Ligand excluded by PLIPOCT.41: 4 residues within 4Å:- Chain A: T.68, L.71, F.125
- Ligands: OCT.42
Ligand excluded by PLIPOCT.42: 1 residues within 4Å:- Ligands: OCT.41
Ligand excluded by PLIPOCT.43: 1 residues within 4Å:- Chain A: Y.74
Ligand excluded by PLIPOCT.44: 2 residues within 4Å:- Chain A: F.76, K.77
Ligand excluded by PLIPOCT.45: 2 residues within 4Å:- Chain A: V.80, L.81
Ligand excluded by PLIPOCT.46: 1 residues within 4Å:- Chain A: L.81
Ligand excluded by PLIPOCT.47: 6 residues within 4Å:- Chain A: F.269, G.270, L.273, G.274, E.277
- Ligands: OCT.48
Ligand excluded by PLIPOCT.48: 1 residues within 4Å:- Ligands: OCT.47
Ligand excluded by PLIPOCT.51: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPOCT.52: 8 residues within 4Å:- Chain A: L.497, Y.501
- Chain B: Y.204, V.492, L.496
- Ligands: C14.30, D10.60, D10.62
Ligand excluded by PLIPOCT.53: 2 residues within 4Å:- Ligands: OCT.54, D10.64
Ligand excluded by PLIPOCT.54: 4 residues within 4Å:- Chain B: I.60, F.64, R.197
- Ligands: OCT.53
Ligand excluded by PLIPOCT.56: 5 residues within 4Å:- Chain B: F.241, Y.245, F.481
- Ligands: OCT.57, D10.87
Ligand excluded by PLIPOCT.57: 7 residues within 4Å:- Chain B: F.241, T.474, V.477
- Ligands: D10.55, OCT.56, OCT.75, C14.77
Ligand excluded by PLIPOCT.65: 1 residues within 4Å:- Chain B: F.307
Ligand excluded by PLIPOCT.67: 8 residues within 4Å:- Chain B: G.91, V.92, L.95, F.294, M.420, V.424, T.428
- Ligands: D10.66
Ligand excluded by PLIPOCT.72: 1 residues within 4Å:- Ligands: D12.71
Ligand excluded by PLIPOCT.75: 3 residues within 4Å:- Ligands: OCT.57, D10.76, C14.78
Ligand excluded by PLIPOCT.84: 1 residues within 4Å:- Chain B: G.263
Ligand excluded by PLIPOCT.88: 1 residues within 4Å:- Chain B: Y.62
Ligand excluded by PLIPOCT.89: 4 residues within 4Å:- Chain B: T.68, L.71, F.125
- Ligands: OCT.90
Ligand excluded by PLIPOCT.90: 1 residues within 4Å:- Ligands: OCT.89
Ligand excluded by PLIPOCT.91: 1 residues within 4Å:- Chain B: Y.74
Ligand excluded by PLIPOCT.92: 2 residues within 4Å:- Chain B: F.76, K.77
Ligand excluded by PLIPOCT.93: 2 residues within 4Å:- Chain B: V.80, L.81
Ligand excluded by PLIPOCT.94: 1 residues within 4Å:- Chain B: L.81
Ligand excluded by PLIPOCT.95: 5 residues within 4Å:- Chain B: F.269, G.270, L.273, G.274, E.277
Ligand excluded by PLIP- 33 x D10: DECANE(Non-functional Binders)(Non-covalent)
D10.7: 2 residues within 4Å:- Ligands: CLR.2, OCT.9
Ligand excluded by PLIPD10.12: 6 residues within 4Å:- Chain A: I.348, D.485, Y.486, L.488, I.489
- Ligands: OCT.4
Ligand excluded by PLIPD10.13: 2 residues within 4Å:- Ligands: CLR.2, CLR.50
Ligand excluded by PLIPD10.14: 4 residues within 4Å:- Chain A: Y.204
- Chain B: Q.504
- Ligands: OCT.4, D10.76
Ligand excluded by PLIPD10.16: 3 residues within 4Å:- Chain A: C.196
- Ligands: OCT.5, D12.15
Ligand excluded by PLIPD10.18: 6 residues within 4Å:- Chain A: V.298, T.301, G.302, L.431, F.432
- Ligands: OCT.19
Ligand excluded by PLIPD10.20: 2 residues within 4Å:- Chain A: L.423, L.426
Ligand excluded by PLIPD10.21: 1 residues within 4Å:- Ligands: D10.22
Ligand excluded by PLIPD10.22: 5 residues within 4Å:- Chain A: Y.118, L.326, P.327, F.388
- Ligands: D10.21
Ligand excluded by PLIPD10.28: 4 residues within 4Å:- Chain A: Y.501
- Ligands: OCT.27, C14.30, D10.62
Ligand excluded by PLIPD10.31: 2 residues within 4Å:- Chain A: L.458, W.462
Ligand excluded by PLIPD10.32: 4 residues within 4Å:- Chain A: F.455, S.456, P.459
- Ligands: D10.33
Ligand excluded by PLIPD10.33: 4 residues within 4Å:- Chain A: M.453, F.455, S.456
- Ligands: D10.32
Ligand excluded by PLIPD10.34: 6 residues within 4Å:- Chain A: V.248, L.251, Q.252
- Ligands: HP6.26, D10.35, D10.40
Ligand excluded by PLIPD10.35: 3 residues within 4Å:- Chain A: L.251, V.254
- Ligands: D10.34
Ligand excluded by PLIPD10.36: 2 residues within 4Å:- Chain A: F.230, L.262
Ligand excluded by PLIPD10.40: 1 residues within 4Å:- Ligands: D10.34
Ligand excluded by PLIPD10.55: 2 residues within 4Å:- Ligands: CLR.50, OCT.57
Ligand excluded by PLIPD10.60: 6 residues within 4Å:- Chain B: I.348, D.485, Y.486, L.488, I.489
- Ligands: OCT.52
Ligand excluded by PLIPD10.61: 2 residues within 4Å:- Ligands: CLR.2, CLR.50
Ligand excluded by PLIPD10.62: 4 residues within 4Å:- Chain A: Q.504
- Chain B: Y.204
- Ligands: D10.28, OCT.52
Ligand excluded by PLIPD10.64: 3 residues within 4Å:- Chain B: C.196
- Ligands: OCT.53, D12.63
Ligand excluded by PLIPD10.66: 6 residues within 4Å:- Chain B: V.298, T.301, G.302, L.431, F.432
- Ligands: OCT.67
Ligand excluded by PLIPD10.68: 2 residues within 4Å:- Chain B: L.423, L.426
Ligand excluded by PLIPD10.69: 1 residues within 4Å:- Ligands: D10.70
Ligand excluded by PLIPD10.70: 5 residues within 4Å:- Chain B: Y.118, L.326, P.327, F.388
- Ligands: D10.69
Ligand excluded by PLIPD10.76: 4 residues within 4Å:- Chain B: Y.501
- Ligands: D10.14, OCT.75, C14.78
Ligand excluded by PLIPD10.79: 2 residues within 4Å:- Chain B: L.458, W.462
Ligand excluded by PLIPD10.80: 4 residues within 4Å:- Chain B: F.455, S.456, P.459
- Ligands: D10.81
Ligand excluded by PLIPD10.81: 4 residues within 4Å:- Chain B: M.453, F.455, S.456
- Ligands: D10.80
Ligand excluded by PLIPD10.82: 6 residues within 4Å:- Chain B: V.248, L.251, Q.252
- Ligands: HP6.74, D10.83, D10.87
Ligand excluded by PLIPD10.83: 3 residues within 4Å:- Chain B: L.251, V.254
- Ligands: D10.82
Ligand excluded by PLIPD10.87: 2 residues within 4Å:- Ligands: OCT.56, D10.82
Ligand excluded by PLIP- 10 x D12: DODECANE(Non-covalent)
D12.10: 5 residues within 4Å:- Chain A: C.192, T.333, F.336
- Ligands: HEX.25, D12.39
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:T.333, A:F.336
D12.11: 3 residues within 4Å:- Chain A: F.191, N.330, S.383
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:F.191
D12.15: 4 residues within 4Å:- Chain A: C.196, R.197, F.200
- Ligands: D10.16
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:F.200
D12.23: 3 residues within 4Å:- Chain A: P.328, L.387
- Ligands: OCT.24
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:P.328, A:L.387
D12.39: 4 residues within 4Å:- Chain A: I.189, H.337, I.344
- Ligands: D12.10
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:I.189, A:H.337, A:I.344
D12.58: 5 residues within 4Å:- Chain B: C.192, T.333, F.336
- Ligands: HEX.73, D12.86
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:T.333, B:F.336
D12.59: 3 residues within 4Å:- Chain B: F.191, N.330, S.383
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:F.191
D12.63: 4 residues within 4Å:- Chain B: C.196, R.197, F.200
- Ligands: D10.64
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:F.200
D12.71: 3 residues within 4Å:- Chain B: P.328, L.387
- Ligands: OCT.72
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:P.328, B:L.387
D12.86: 4 residues within 4Å:- Chain B: I.189, H.337, I.344
- Ligands: D12.58
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:I.189, B:H.337, B:I.344
- 2 x HEX: HEXANE(Non-functional Binders)
- 4 x HP6: HEPTANE(Non-covalent)
HP6.26: 4 residues within 4Å:- Chain A: V.243, V.244, T.247
- Ligands: D10.34
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:V.243, A:V.244
HP6.38: 5 residues within 4Å:- Chain A: C.260, G.263, V.264, L.309
- Ligands: OCT.37
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:V.264, A:L.309
HP6.74: 4 residues within 4Å:- Chain B: V.243, V.244, T.247
- Ligands: D10.82
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:V.243, B:V.244
HP6.85: 1 residues within 4Å:- Chain B: M.267
No protein-ligand interaction detected (PLIP)- 4 x C14: TETRADECANE(Non-covalent)
C14.29: 5 residues within 4Å:- Chain A: K.466, T.470, L.473
- Ligands: OCT.9, C14.30
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:K.466, A:T.470, A:L.473
C14.30: 7 residues within 4Å:- Chain A: K.466, I.467, Y.501
- Ligands: OCT.27, D10.28, C14.29, OCT.52
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:I.467
C14.77: 5 residues within 4Å:- Chain B: K.466, T.470, L.473
- Ligands: OCT.57, C14.78
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:K.466, B:T.470, B:L.473
C14.78: 7 residues within 4Å:- Chain B: K.466, I.467, Y.501
- Ligands: OCT.4, OCT.75, D10.76, C14.77
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:I.467
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ge, J. et al., Molecular mechanism of prestin electromotive signal amplification. Cell (2021)
- Release Date
- 2021-08-25
- Peptides
- Prestin: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-dimer
- Ligands
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x CLR: CHOLESTEROL(Non-covalent)
- 38 x OCT: N-OCTANE(Non-functional Binders)(Non-covalent)
- 33 x D10: DECANE(Non-functional Binders)(Non-covalent)
- 10 x D12: DODECANE(Non-covalent)
- 2 x HEX: HEXANE(Non-functional Binders)
- 4 x HP6: HEPTANE(Non-covalent)
- 4 x C14: TETRADECANE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ge, J. et al., Molecular mechanism of prestin electromotive signal amplification. Cell (2021)
- Release Date
- 2021-08-25
- Peptides
- Prestin: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.